A Shortcut from Genome to Drug: The Employment of Bioinformatic Tools to Find New Targets for Gastric Cancer Treatment

Gastric cancer (GC) is a highly heterogeneous, complex disease and the fifth most common cancer worldwide (about 1 million cases and 784,000 deaths worldwide in 2018). GC has a poor prognosis (the 5-year survival rate is less than 20%), but there is an effort to find genes highly expressed during tu...

Descripción completa

Detalles Bibliográficos
Autores principales: Brito, Daiane M. S., Lima, Odnan G., Mesquita, Felipe P., da Silva, Emerson L., de Moraes, Maria E. A., Burbano, Rommel M. R., Montenegro, Raquel C., Souza, Pedro F. N.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10535099/
https://www.ncbi.nlm.nih.gov/pubmed/37765273
http://dx.doi.org/10.3390/pharmaceutics15092303

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10535099/
https://www.ncbi.nlm.nih.gov/pubmed/37765273
http://dx.doi.org/10.3390/pharmaceutics15092303

Ejemplares similares